In contemplating the discontinuation of in-home isolation for immunocompromised COVID-19 patients, one must prioritize caution and thorough assessment. Understanding the risks of prolonged, viral shedding and heightened vulnerability to severe illness underscores the importance of informed decision-making, guided by medical expertise and community safety concerns.
------------------------------
niladri11 basu
mumbai AL
------------------------------
Original Message:
Sent: 03-02-2024 04:41
From: riju nag
Subject: Discontinuation of in-home isolation for immunocompromised patients with COVID19
Discontinuation of in-home isolation for immunocompromised patients with COVID-19 warrants careful consideration. While immunocompromised individuals may exhibit prolonged viral shedding, their risk of severe illness remains heightened. Thus, discontinuation of isolation should be guided by clinical assessment, viral load monitoring, and consultation with healthcare providers to ensure adequate protection for both the patient and the community.
------------------------------
riju nag A
MUMBAI MS
Original Message:
Sent: 03-19-2020 16:29
From: Navneet Majhail
Subject: Discontinuation of in-home isolation for immunocompromised patients with COVID19
See link below for CDC interim guidance for discontinuing in-home isolation for immunocompromised patients with COVID19 (includes BMT recipients). Here is the gist:
Maintain home isolation until:
- Resolution of fever without the use of fever-reducing medications and
- Improvement in respiratory symptoms (e.g., cough, shortness of breath) and
- Negative results of an FDA Emergency Use Authorized molecular assay for COVID-19 from at least two consecutive nasopharyngeal swab specimens collected ≥24 hours apart (total of two negative specimens)
https://www.cdc.gov/coronavirus/2019-ncov/hcp/ending-isolation.html
------------------------------
Navneet Majhail MD, MS
Cleveland Clinic
Cleveland OH
(216) 444-2199
------------------------------